Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 1825 Records) |
| Query Trace: Neoplasms and Pik3ca[original query] |
|---|
| Genomic landscape of circulating tumor DNA in HER2-low metastatic breast cancer. Signal transduction and targeted therapy 2024 12 9 (1): 345. Zongbi Yi, Kaixiang Feng, Dan Lv, Yanfang Guan, Youcheng Shao, Fei Ma, Binghe |
| Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study. The Lancet. Oncology 2024 12 25 (12): e629-e638. Hope S Rugo, Florence Lerebours, Eva Ciruelos, Pamela Drullinsky, Manuel Ruiz-Borrego, Patrick Neven, Yeon Hee Park, Aleix Prat, Thomas Bachelot, Dejan Juric, Nicholas Turner, Nickolas Sophos, Juan Pablo Zarate, Christina Arce, Yu-Ming Shen, Stuart Turner, Hemanth Kanakamedala, Wei-Chun Hsu, Stephen Ch |
| Association of SIGLEC9 Expression with Cytokine Expression, Tumor Grading, KRAS, NRAS, BRAF, PIK3CA, AKT Gene Mutations, and MSI Status in Colorectal Cancer. Current issues in molecular biology 2024 12 46 (12): 13617-13646. B?a?ej Ochman, Anna Kot, Sylwia Mielcarska, Agnieszka Kula, Miriam Dawidowicz, Dominika Koszewska, Dorota Hudy, Monika Szrot, Jerzy Piecuch, Dariusz Waniczek, Zenon Czuba, El?bieta ?wi?tochows |
| IDENTIFICATION OF CLINICALLY RELEVANT GENE VARIANTS IN COLON ADENOCARCINOMA SAMPLES OF UKRAINIAN PATIENTS USING A COMPREHENSIVE CANCER PANEL: A PILOT STUDY. Experimental oncology 2024 12 46 (3): 221-227. G Gerashchenko, R Gulkovskyi, N Melnichuk, N Hryshchenko, T Marchyshak, O Mankovska, A Bezverkhiy, I Kotuza, L Rosha, A Kotuza, Z Tkachuk, V Kashuba, M Tuka |
| Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers. Communications medicine 2024 12 4 (1): 256. Reagan M Barnett, Albert Jang, Sree Lanka, PIngfu Fu, Leslie A Bucheit, Hani Babiker, Alan Bryce, Haley M Meyer, Yujin Choi, Casey Moore, Rohan Garje, Xin Gao, Dae Won Kim, Richard Y Chang, Pat Gulhati, Ryne Ramaker, Rani Bansal, Tian Zhang, A Oliver Sartor, Andrew J Armstrong, Mehmet A Bilen, Pedro Bara |
| Landscape and prognostic significance of oncogene drivers in metastatic castration sensitive prostate cancer. Translational cancer research 2024 12 13 (11): 6235-6245. Theodore Wang, Jongmyung Kim, Ritesh Kumar, Rebecca A Deek, Ryan Stephenson, Tina Mayer, Biren Saraiya, Saum Ghodoussipour, Thomas Jang, David Golombos, Vignesh Packiam, Ronald Ennis, Lara Hathout, Salma K Jabbour, Ozan Guler, Cem Onal, Matthew P De |
| Patterns of genomic instability in?>?2000 patients with ovarian cancer across six clinical trials evaluating olaparib. Genome medicine 2024 12 16 (1): 145. Alan Barnicle, Isabelle Ray-Coquard, Etienne Rouleau, Karen Cadoo, Fiona Simpkins, Carol Aghajanian, Alexandra Leary, Andrés Poveda, Stephanie Lheureux, Eric Pujade-Lauraine, Benoit You, Jonathan Ledermann, Ursula Matulonis, Charlie Gourley, Kirsten M Timms, Zhongwu Lai, Darren R Hodgson, Cathy E Elks, Simon Dearden, Coumaran Egile, Pierre Lao-Sirieix, Elizabeth A Harrington, Jessica S Bro |
| Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA Assay. BMC cancer 2024 12 24 (1): 1547. Mariana Bisarro Dos Reis, Wellington Dos Santos, Ana Carolina de Carvalho, Adhara Brandão Lima, Monise Tadin Reis, Florinda Santos, Rui Manuel Reis, Denise Peixoto Guimarã |
| PIK3CA Mutations and Co-Mutations in Operated Non-Small Cell Lung Carcinoma. Journal of clinical medicine 2024 12 13 (23): . Salih Cokpinar, Ibrahim Halil Erdogdu, Seda Orenay-Boyacioglu, Olcay Boyacioglu, Nesibe Kahraman-Cetin, Ibrahim Meteog |
| Surveillance of Disease Progression in Metastatic Breast Cancer by Molecular Counting of Circulating Tumor DNA Using Plasma-SeqSensei Breast Cancer in Vitro Diagnostics Assay. The Journal of molecular diagnostics : JMD 2024 11 . Geert A Martens, Jan Demol, Franceska Dedeurwaerdere, Kristof De Smet, Janusz Wesolowski, Dieter De Sm |
| The molecular landscape of 227 adult granulosa cell tumors of the ovary: Insights into the progression from primary to recurrence. Laboratory investigation; a journal of technical methods and pathology 2024 11 102201. Romana Michálková, Adam Šafanda, Nikola Hájková, Jan Hojný, Eva Krkavcová, Michaela Kendall Bárt?, Marián Švajdler, Tetiana Shatokhina, Jan Laco, Radoslav Mat?j, Gábor Méhes, Jitka Hausnerová, Jozef Škarda, Mária Hácová, Monika Náležinská, Tomáš Zima, Pavel Dundr, Kristýna N?mejco |
| Targeted Sequencing of HER2-Positive Breast Cancer Mutations Revealed a Potential Association between PIK3CA and Trastuzumab Resistance. Asian Pacific journal of cancer prevention : APJCP 2024 11 25 (11): 4051-4059. Asmaa Mohamed Mekhamer, Marwa Hanafi Saied, Dalia Abd Elmoaty Elneily, Tarek Abdel Halim El-Fayoumi, Doaa Ibrahim Hash |
| Integrative multi-omics profiling of colorectal cancer from a Hispanic/Latino cohort of patients. medRxiv : the preprint server for health sciences 2024 11 . B Waldrup, F Carranza, Y Jin, Y Amzaleg, M Postel, D W Craig, J D Carpten, B Salhia, C N Ricker, J O Culver, C E Chavez, M C Stern, L Baezconde-Garbanati, H J Lenz, E I Velazquez-Villarre |
| Immune landscape of the tumour microenvironment in Ethiopian breast cancer patients. Breast cancer research : BCR 2024 11 26 (1): 162. Meron Yohannes, Zelalem Desalegn, Marcus Bauer, Kathrin Stückrath, Endale Anberbir, Yonas Bekuretsion, Mathewos Assefa, Tariku Wakuma, Yasin Worku, Pablo S C Santos, Lesley Taylor, Adamu Adissie, Claudia Wickenhauser, Chiara Massa, Martina Vetter, Eva Johanna Kantelhardt, Barbara Seliger, Tamrat Abe |
| Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer. Molecular cancer 2024 11 23 (1): 264. Luís Nunes, Jakob Mørkved Stenersen, Kushtrim Kryeziu, Tobias Sjöblom, Bengt Glimelius, Ragnhild A Lothe, Anita Sve |
| HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01. Nature communications 2024 11 15 (1): 10213. Salvatore Siena, Kanwal Raghav, Toshiki Masuishi, Kensei Yamaguchi, Tomohiro Nishina, Elena Elez, Javier Rodriguez, Ian Chau, Maria Di Bartolomeo, Hisato Kawakami, Fumitaka Suto, Makito Koga, Koichiro Inaki, Yusuke Kuwahara, Issey Takehara, Daniel Barrios, Kojiro Kobayashi, Axel Grothey, Takayuki Yoshi |
| Prognostic significance of actionable next-generation sequencing multigene panel in esophageal cancer treatment. European review for medical and pharmacological sciences 2024 11 28 (21): 4515-4525. Z Teke, A Bisgin, C Oruc Rencuzogullari, K Eren Erdogan, C K Parsak, S Kalkanli T |
| The tissue and circulating cell-free DNA-derived genetic landscape of premalignant colorectal lesions and its application for early diagnosis of colorectal cancer. MedComm 2024 11 5 (12): e70011. Qingjian Chen, Yu-Hong Xu, Shiyang Kang, WuHao Lin, Linna Luo, Luping Yang, Qi-Hua Zhang, Pan Yang, Jia-Qian Huang, Xiaoni Zhang, Jing Zhang, Qi Zhao, Rui-Hua Xu, Hui-Yan L |
| LRP1B associated with immune cell infiltration influenced the efficacy of immunotherapy in colorectal cancer patients. Clinics (Sao Paulo, Brazil) 2024 11 79 100516. Weiming Weng, Shengquan He, Guoxiong Zhang, Xindong Zhou, Kang Li, Jiajun L |
| Molecular and Clinicopathologic Characterization of HER2-overexpressed Squamous Cell Carcinoma of the Cervix. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2024 10 . Rachelle P Mendoza, Madhurya Ramineni, Kristina Doytcheva, Elmer C Gabutan, Raavi Gupta, Cole Miller, Donghyuk Choi, Anusha Vemuri, Renee Briese, Lisa Brannon, Anum Shahid, Kristin Petras, Minhaz Ud Dean, Carrie Fitzpatrick, Jeremy Segal, Peng Wang, Ricardo R Last |
| Clinicopathogenomic analysis of PI3K/AKT/PTEN-altered luminal metastatic breast cancer in Japan. Breast cancer (Tokyo, Japan) 2024 10 . Hiroshi Tada, Minoru Miyashita, Narumi Harada-Shoji, Akiko Ebata, Miku Sato, Tokiwa Motonari, Mika Yanagaki, Tomomi Kon, Aru Sakamoto, Takanori Ishi |
| Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy. Journal of translational medicine 2024 10 22 (1): 969. François Bertucci, Arnaud Guille, Florence Lerebours, Michele Ceccarelli, Najeeb Syed, José Adélaïde, Pascal Finetti, Naoto T Ueno, Steven Van Laere, Patrice Viens, Alexandre De Nonneville, Anthony Goncalves, Daniel Birnbaum, Céline Callens, Davide Bedognetti, Emilie Mamessi |
| Predictive Molecular Biomarkers of Bladder Cancer Identified by Next-Generation Sequencing-Preliminary Data. Journal of clinical medicine 2025 1 13 (24): . Aleksander Myszka, Marek Ciesla, Aleksandra Siekierzynska, Anna Sendera, Constantina Constantinou, Pawel Karpinski, Grzegorz Wysiadecki, Krzysztof Balawend |
| Frequency of somatic and germline variants of predisposition genes in young Chinese women with breast cancer. Breast cancer research and treatment 2025 1 . Yuchun Xu, Qindong Cai, Jing Li, Wenhui Guo, Lili Chen, Minyan Chen, Yuxiang Lin, Yali Wang, Weifeng Cai, Yibin Qiu, Peng He, Shunyi Liu, Chuan Wang, Fangmeng |
| Molecular subtype of ovarian clear cell carcinoma: an analysis of 80 Chinese patients using the TCGA molecular classification of endometrial cancer. BMC cancer 2025 1 25 (1): 90. Wei Chen, Lu Yan, Qin Li, Shuling Zhou, Ting Hou, Huijuan Yang, Shuang |
| Molecular and clinical traits of HER2-low breast cancer patients and their relationship with neoadjuvant treatment effectiveness. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2025 1 . Wei Zhao, Mingxiang Zhang, Bohui Zhu, Yueyin Pan, Yiyuan S |
| Buparlisib and Paclitaxel in Patients with Head and Neck Squamous Cell Carcinoma: Immunogenomic Biomarkers of Efficacy from the BERIL-1 Study. Targeted oncology 2025 1 . Antoine Desilets, Justin Lucas, Lisa F Licitra, Sunny Lu, Archie Tse, Tom Tang, Kevin Dreyer, Nanhai He, Lars E Birgerson, Sandrine Faivre, Denis Soulièr |
| Predicting breast cancer prognosis using PR and PIK3CA biomarkers: a comparative analysis of diagnostic groups. BMC cancer 2025 1 25 (1): 68. Yuting Feng, Qingzhen Song, Lei Yan, Ruoqi Li, Mengqin Yang, Peng Bu, Jing Li |
| Identification of clinicopathological-specific driver gene and genetic subtyping of colorectal cancer. Cancer science 2025 1 . Jianjiong Li, Chunnian Wang, Changshun Yang, Hua Bao, Ningyou Li, Xianqiang Huang, Wei Gong, Xinyue Hong, Jiani C Yin, Jiaohui Pang, Meifu Gan, Danping Yu |
| Associations between PIK3CA Mutations and Disease Free Survival in Patients with HR+, HER2- Tumors Treated with Adjuvant Hormonal Therapy: A Real-World Study in Croatia. The breast journal 2025 1 2024 5648845. Dora ?erina Pavlinovi?, Natalija Dedi? Plaveti?, Ingrid Belac Lovasi?, Robert Šeparovi?, Josipa Flam, Marija Pancirov, Žarko Baji?, Snježana Tomi?, Eduard Vrdolj |
- Page last reviewed:Feb 1, 2024
- Content source: